Trials / Completed
CompletedNCT04307784
The Effects of Vitamin D3 Alone and in a Combination With Omega-3 on the Association of C-peptide With Glycemic Control
The Effects of Vitamin D3 Supplementation Alone and in a Combination With Omega-3 on the Association of C-peptide With Glycemic Control; A Randomized Controlled Trial in People With Vitamin D Deficiency
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 115 (actual)
- Sponsor
- Applied Science Private University · Academic / Other
- Sex
- All
- Age
- 30 Years – 64 Years
- Healthy volunteers
- Accepted
Summary
The Effects of Vitamin D3 alone and in a combination with omega-3 on the association of C-peptide with glycemic control
Detailed description
The data bout the effects of Vitamin D3 (VD3) alone and as a combination with omega-3 fatty acids (Omega-3FA) on the association between C-peptide (CP) and the glycated hemoglobin (HbA1c) is scarce, conflicting and nothing published in the literature review on the combined effect of VD3 and Omega-3FA as a combination on the association of CP with glycemic control. This study will be conducted to investigate the effects of (VD3) alone and as a combination with Omega-3FA on the association between CP as an insulin secretion marker, and glycemic control parameters represented by glycated Hemoglobin (HbA1c), on people with vitamin D deficiency (VDD). This randomized, placebo-controlled trial is designed to test the effects of (50,000 IU VD3/ weekly) and (300mg omega-3FA/daily) separately and as a combination for eight weeks, on the serum levels of CP, 25-hydroxy vitamin D (25OHD) and HbA1c. this study will be carried out during winter on 120 healthy Jordanian males and females with VDD with age range (25-50) years. Fasting serum levels for 25OHD, CP, HbA1c, PTH, Calcium, Phosphate, ALT (Alanine aminotransferase) and Urea were assessed at baseline and at the end of the trial.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | VD3 | VD3 (50.000 IU/week) for 8 weeks |
| DIETARY_SUPPLEMENT | Omega-3FA | Omaga-3FA (300 mg/day) for 8 weeks |
| DIETARY_SUPPLEMENT | VD3 and Omega-3FA | VD3 (50.000 IU/week) and (Omega-3FA 300 mg /day) for 8 weeks |
| OTHER | Control | No intervention is given |
Timeline
- Start date
- 2020-03-10
- Primary completion
- 2020-06-10
- Completion
- 2020-06-30
- First posted
- 2020-03-13
- Last updated
- 2020-07-14
Locations
1 site across 1 country: Jordan
Source: ClinicalTrials.gov record NCT04307784. Inclusion in this directory is not an endorsement.